Wang S J, Sihra T S, Gean P W
Department of Pharmacology, University College London, London, WC1E 6BT, UK.
Neuroreport. 2001 Jul 20;12(10):2255-8. doi: 10.1097/00001756-200107200-00042.
Lamotrigine (LAG) is an antiepileptic drug which is believed to suppress seizures by inhibiting the release of excitatory neurotransmitters. The present study was aimed at investigating the effect of LAG on the 4-aminopyridine (4AP)-evoked glutamate release in cerebrocortical nerve terminals (synaptosomes). LAG inhibited the release of glutamate evoked by 4AP in a concentration-dependent manner. This inhibitory effect was associated with a reduction in the depolarization-evoked increase in the cytoplasmic free Ca2+ concentration ([Ca2+]C). In addition, LAG did not alter the resting synaptosomal membrane potential or 4AP-evoked depolarization. Furthermore, ionomycin-evoked glutamate release was not affected by LAG. Based on these results, we suggest that presynaptic calcium influx blockade and inhibition of glutamate release may underlie the mechanism of action of LAG. These action may also contribute to their neuroprotective properties in excitotoxic injury.
拉莫三嗪(LAG)是一种抗癫痫药物,据信它通过抑制兴奋性神经递质的释放来抑制癫痫发作。本研究旨在探讨LAG对4-氨基吡啶(4AP)诱发的大脑皮质神经末梢(突触体)谷氨酸释放的影响。LAG以浓度依赖性方式抑制4AP诱发的谷氨酸释放。这种抑制作用与去极化诱发的细胞质游离Ca2+浓度([Ca2+]C)升高的降低有关。此外,LAG不会改变静息突触体膜电位或4AP诱发的去极化。此外,离子霉素诱发的谷氨酸释放不受LAG影响。基于这些结果,我们认为突触前钙内流阻断和谷氨酸释放抑制可能是LAG作用机制的基础。这些作用也可能有助于其在兴奋性毒性损伤中的神经保护特性。